Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARTV | AZN | AMGN | GILD | BMY |
| Company | Artiva Biotherapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.60 | 183.25 | 336.23 | 132.27 | 56.64 |
| High | 10.70 | 183.44 | 336.23 | 132.81 | 56.98 |
| Low | 10.25 | 181.57 | 328.34 | 129.57 | 56.14 |
| Latest | 10.26 | 181.68 | 327.75 | 130.18 | 56.27 |
| Change | -0.42 | -3.28 | -5.96 | -1.88 | -0.50 |
| % Change | -3.93% | -1.77% | -1.79% | -1.42% | -0.88% |
| Volume | 58,633 | 366,172 | 470,928 | 1,319,827 | 1,403,854 |
| 20-Day Average Volume | 564,955 | 2,017,529 | 2,531,252 | 5,957,476 | 9,668,053 |
| Previous Close | 10.68 | 184.96 | 333.71 | 132.06 | 56.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.97 | 187.05 | 337.10 | 132.31 | 57.62 |
| 20-Day Raw Stochastic | 31.28% | 9.03% | 26.73% | 24.72% | 17.58% |
| 20-Day Relative Strength | 54.49 | 41.14 | 41.87 | 42.06 | 44.20 |
| Weighted Alpha | +25.81 | +24.81 | +15.91 | +20.82 | +20.09 |
| Today's Opinion | 88% Buy | 24% Sell | 24% Sell | 8% Sell | 8% Buy |
| Previous Opinion | 88% Buy | 16% Sell | 24% Sell | 8% Sell | 8% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.50% since 05/08/26 | -0.40% since 05/08/26 | -0.44% since 05/08/26 | -0.76% since 05/08/26 | +0.34% since 05/08/26 |
| Low | 10.23 on 05/13/26 | 181.60 on 05/15/26 | 327.62 on 05/11/26 | 129.57 on 05/15/26 | 55.40 on 05/11/26 |
| High | 11.77 on 05/12/26 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.04 on 05/14/26 |
| 1-Month | |||||
| %Chg | +14.29% since 04/15/26 | -9.49% since 04/15/26 | -5.16% since 04/15/26 | -6.75% since 04/15/26 | -2.66% since 04/15/26 |
| Low | 8.52 on 04/29/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 14.53 on 04/20/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.26 on 04/16/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +160.00% since 02/13/26 | -11.40% since 02/13/26 | -10.55% since 02/13/26 | -15.90% since 02/13/26 | -7.23% since 02/13/26 |
| Low | 3.87 on 02/17/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 14.53 on 04/20/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +220.00% since 11/14/25 | +2.19% since 11/14/25 | -1.93% since 11/14/25 | +4.25% since 11/14/25 | +20.79% since 11/14/25 |
| Low | 2.96 on 12/09/25 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 14.53 on 04/20/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 263,977 | 286,855,936 | 181,458,304 | 163,961,728 | 115,928,368 |
| Shares Outstanding, K | 24,717 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -83,870,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -23,520,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 2.86 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.95 on 05/08/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/05/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.27 | 15.22 | 15.90 | 9.51 |